Drug name - Astepro

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518919 MYLAN SPECIALITY LP Compositions comprising azelastine and methods of use thereof Nov, 2025

(3 years from now)

US9919050 MYLAN SPECIALITY LP Compositions comprising azelastine Nov, 2025

(3 years from now)

US8071073 MYLAN SPECIALITY LP Compositions comprising azelastine and methods of use thereof Jun, 2028

(5 years from now)

Drugs and Companies using AZELASTINE HYDROCHLORIDE ingredient

Treatment: Treatment of allergic rhinitis, including seasonal and perennial allergic rhinitis

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.137MG/SPRAY SPRAY, METERED;NASAL Discontinued
0.2055MG/SPRAY SPRAY, METERED;NASAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.